Gene · 8740
Papers1,880
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,880
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Caprin-1 influences autophagy-induced tumor growth and immune modulation in pancreatic cancer. | J Transl Med | 2023 | 38082307 | PubTator, text mining | PubMed |
| Screening for Circulating Inflammatory Proteins Does Not Reveal Plasma Biomarkers of Constant Tinnitus. | J Assoc Res Otolaryngol | 2023 | 38079022 | PubTator, text mining | PubMed |
| Immune checkpoints in rheumatoid arthritis: progress and promise. | Front Immunol | 2023 | 38077329 | PubTator, text mining | PubMed |
| TPD52L2 as a potential prognostic and immunotherapy biomarker in clear cell renal cell carcinoma. | Front Oncol | 2023 | 38074636 | PubTator, text mining | PubMed |
| Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer. | Front Oncol | 2023 | 38074633 | PubTator, text mining | PubMed |
| Recent Advances in Surface Plasmon Resonance (SPR) Technology for Detecting Ovarian Cancer Biomarkers. | Cancers (Basel) | 2023 | 38067311 | PubTator, text mining | PubMed |
Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype. | Cancers (Basel) | 2023 | 38067234 | PubTator, text mining | PubMed |
| Identification and validation of 5-methylcytosine-associated genes in diffuse large B-cell lymphoma. | Heliyon | 2023 | 38045198 | PubTator, text mining | PubMed |
| Computational analysis of five neurodegenerative diseases reveals shared and specific genetic loci. | Comput Struct Biotechnol J | 2023 | 38022694 | PubTator, text mining | PubMed |
| Overexpression of FNDC4 constrains ovarian cancer progression by promoting cell apoptosis and inhibiting cell growth. | J Cancer | 2023 | 38021165 | PubTator, text mining | PubMed |
| Identification of A Novel Gene Signature Combining Ferroptosis- and Immunity-Related Genes for Prognostic Prediction, Immunotherapy and Potential Therapeutic Targets in Gastric Cancer. | J Cancer | 2023 | 38021154 | PubTator, text mining | PubMed |
| Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma. | BMC Cancer | 2023 | 38012562 | PubTator, text mining | PubMed |
| Characterization of cancer-associated fibroblasts (CAFs) and development of a CAF-based risk model for triple-negative breast cancer. | Cancer Cell Int | 2023 | 38007443 | PubTator, text mining | PubMed |
| Dpep Inhibits Cancer Cell Growth and Survival via Shared and Context-Dependent Transcriptome Perturbations. | Cancers (Basel) | 2023 | 38001578 | PubTator, text mining | PubMed |
| Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study. | Sci Rep | 2023 | 37973887 | PubTator, text mining | PubMed |
| A sialyltransferases-related gene signature serves as a potential predictor of prognosis and therapeutic response for bladder cancer. | Eur J Med Res | 2023 | 37968767 | PubTator, text mining | PubMed |
Elaboration and validation of a prognostic signature associated with disulfidoptosis in lung adenocarcinoma, consolidated with integration of single-cell RNA sequencing and bulk RNA sequencing techniques. | Front Immunol | 2023 | 37965333 | PubTator, text mining | PubMed |
| Establishing and Validating an Aging-Related Prognostic Signature in Osteosarcoma. | Stem Cells Int | 2023 | 37964984 | PubTator, text mining | PubMed |
| Viral and host mediators of non-suppressible HIV-1 viremia. | Nat Med | 2023 | 37957382 | PubTator, text mining | PubMed |
| Subtyping of COVID-19 samples based on cell-cell interaction in single cell transcriptomes. | Sci Rep | 2023 | 37949890 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8740/papers?page=11